{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:26:41Z","timestamp":1791235601475,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.stem.2020.09.008","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T10:45:24Z","timestamp":1601549124000},"page":"505-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Solving the Puzzle of Immune Tolerance for \u03b2-Cell Replacement Therapy for Type 1 Diabetes"],"prefix":"10.1016","volume":"27","author":[{"given":"Jeffrey A.","family":"Bluestone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizhi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2020.09.008_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.aac9935","article-title":"MYC regulates the antitumor immune response through CD47 and PD-L1","volume":"352","author":"Casey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.stem.2020.09.008_bib2","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.stem.2020.09.008_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2020.09.008_bib4","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","article-title":"Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells","volume":"38","author":"Hogrebe","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2020.09.008_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in\u00a0vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2020.09.008_bib6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3389\/fimmu.2017.01762","article-title":"Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation","volume":"8","author":"Mahr","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.stem.2020.09.008_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cei.13424","article-title":"Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes","volume":"200","author":"Quandt","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.stem.2020.09.008_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3389\/fbioe.2020.00786","article-title":"Advances Toward Engineering Functionally Mature Human Pluripotent Stem Cell-Derived \u03b2 Cells","volume":"8","author":"Velazco-Cruz","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.stem.2020.09.008_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2631-z","article-title":"Immune-evasive human islet-like organoids ameliorate diabetes","author":"Yoshihara","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.stem.2020.09.008_bib10","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/j.1600-6143.2012.04213.x","article-title":"Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing","volume":"12","author":"You","year":"2012","journal-title":"Am. J. Transplant."}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590920304549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590920304549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:51:59Z","timestamp":1761832319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590920304549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1934590920304549"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2020.09.008","relation":{},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Solving the Puzzle of Immune Tolerance for \u03b2-Cell Replacement Therapy for Type 1 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2020.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}